pembrolizumab
merck
['s1512', 'melanoma', 'pembro']
in 24 of 27 patients with inoperable #desmoplastic #melanoma, cancer responded to treatment with pembrolizumab. s1512 cohort b (unresectable) results at #aacr2023 clinical trials plenary by pi dr. kari kendra 
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.